Literature DB >> 35851684

Association Between Potentially Functional Variants in chr5q14 and the Risk of Cervical Cancer in a Chinese Population.

Yuqing Liu1, Ling Mei2, Yueyue Chen2, Xiaoli Zhang1, Dongmei Wei2, Tao Cui2, Yueting Zhang2, Tao Wang3, Xiaoyu Niu4.   

Abstract

Cervical cancer is a complex polygenic disease, and the interaction between single-nucleotide polymorphisms (SNPs) may lead to differences in the incidence and susceptibility of cervical cancer. In this study, we explored whether three potentially functional SNPs-rs59661306, rs257847, and rs637442 with reference/alternative alleles A/G, C/T, and T/G, respectively-in chr5q14 were related to cervical cancer risk in a Chinese population. A total of 703 samples were collected, including 215 patients with cervical cancer and 488 normal controls. The SNP genotyping was determined by using polymerase chain reaction-restriction fragment length polymorphism. There was an association between the AG rs59661306 genotype or the GG rs59661306 genotype and cervical cancer risk, and the percentage of cancer patients with the A/G rs59661306 genotype plus the percentage of cancer patients with the G/G rs59661306 genotype (AG + GG) was significantly higher than the percentage of AG + GG healthy women in the control group. There was no association between either the rs257847 or the rs637442 and cervical cancer risk. Genotype analysis showed that the genotype CT of rs257847 in combination with the AG, GG, and AG + GG genotypes of rs59661306 were associated with a higher cervical cancer risk, and that the genotypes TG and TG + GG of rs637442 in combination with the AG and AG + GG genotypes of rs59661306 were also associated with a higher cervical cancer risk. These findings indicate that rs59661306, rs257847, and rs637442 may be susceptible loci for cervical cancer. Our study advances the understanding of SNPs that are responsible for cervical cancer susceptibility.
© 2022. The Author(s), under exclusive licence to Society for Reproductive Investigation.

Entities:  

Keywords:  Cervical cancer; Polymorphism; rs257847; rs59661306; rs637442

Year:  2022        PMID: 35851684     DOI: 10.1007/s43032-022-01032-8

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  19 in total

1.  Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection.

Authors:  Fumihiko Takeuchi; Iwao Kukimoto; Zhiqiang Li; Shuang Li; Ni Li; Zhibin Hu; Atsushi Takahashi; Shusaku Inoue; Sana Yokoi; Jianhua Chen; Dong Hang; Makoto Kuroda; Fumihiko Matsuda; Mika Mizuno; Seiichiro Mori; Peng Wu; Naotake Tanaka; Keitaro Matsuo; Yoichiro Kamatani; Michiaki Kubo; Ding Ma; Yongyong Shi
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

2.  Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.

Authors:  Vilvanathan Vinothkumar; Kanagaraj Arun; Ganesan Arunkumar; Sundaramoorthy Revathidevi; Rajendren Ramani; Lakkakula V K S Bhaskar; Avaniyapuram Kannan Murugan; Arasambattu Kannan Munirajan
Journal:  Mol Clin Oncol       Date:  2020-02-26

Review 3.  Cervical cancer: A global health crisis.

Authors:  William Small; Monica A Bacon; Amishi Bajaj; Linus T Chuang; Brandon J Fisher; Matthew M Harkenrider; Anuja Jhingran; Henry C Kitchener; Linda R Mileshkin; Akila N Viswanathan; David K Gaffney
Journal:  Cancer       Date:  2017-05-02       Impact factor: 6.860

Review 4.  Lessons and implications from association studies and post-GWAS analyses of cervical cancer.

Authors:  Dan Chen; Ulf Gyllensten
Journal:  Trends Genet       Date:  2014-11-18       Impact factor: 11.639

5.  Worldwide burden of cervical cancer in 2008.

Authors:  M Arbyn; X Castellsagué; S de Sanjosé; L Bruni; M Saraiya; F Bray; J Ferlay
Journal:  Ann Oncol       Date:  2011-04-06       Impact factor: 32.976

6.  Genome-wide association study of susceptibility loci for cervical cancer.

Authors:  Dan Chen; Ivana Juko-Pecirep; Joanna Hammer; Emma Ivansson; Stefan Enroth; Inger Gustavsson; Lars Feuk; Patrik K E Magnusson; James D McKay; Erik Wilander; Ulf Gyllensten
Journal:  J Natl Cancer Inst       Date:  2013-03-12       Impact factor: 13.506

7.  Expression of the liver-enriched transcription factors C/EBP alpha, C/EBP beta, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver.

Authors:  P Flodby; D Z Liao; A Blanck; K G Xanthopoulos; I P Hällström
Journal:  Mol Carcinog       Date:  1995-02       Impact factor: 4.784

8.  Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies.

Authors:  Priya Duggal; Elizabeth M Gillanders; Taura N Holmes; Joan E Bailey-Wilson
Journal:  BMC Genomics       Date:  2008-10-31       Impact factor: 3.969

9.  Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer.

Authors:  Hanyu Cao; Shuo Yang; Xiuzhang Yu; Mingrong Xi
Journal:  Mol Genet Genomic Med       Date:  2020-09-01       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.